Table 2.
Top 20 PheWAS codes associated with organizational component C6, Oncology I.
| Code | Description | Predicted probability |
|---|---|---|
| 585.1 | Acute renal failure | 1.000 |
| 197 | Chemotherapy | 0.769 |
| 204.21 | Myeloid leukemia, acute | 0.688 |
| 288.11 | Neutropenia | 0.534 |
| 509.1 | Respiratory failure | 0.506 |
| 284 | Aplastic anemia | 0.496 |
| 480 | Pneumonia | 0.489 |
| 401.1 | Essential hypertension | 0.478 |
| 198.2 | Secondary malignancy of lung | 0.463 |
| 198 | Secondary malignant neoplasm | 0.443 |
| 202.2 | Non-Hodgkins lymphoma | 0.440 |
| 081 | Infection/inflammation of internal prosthetic device, implant, or graft | 0.430 |
| 198.6 | Secondary malignancy of bone | 0.409 |
| 287.3 | Thrombocytopenia | 0.390 |
| 284.1 | Pancytopenia | 0.358 |
| 783 | Fever of unknown origin | 0.357 |
| 198.4 | Secondary malignant neoplasm of liver | 0.355 |
| 198.1 | Secondary malignancy of lymph nodes | 0.348 |
| 204.4 | Multiple myeloma | 0.343 |
| 198.5 | Secondary malignancy of brain/spine | 0.319 |
The predicted probability is normalized into a range of [0,1] by using min–max normalization.